Aspects of technology in anaesthesia
On 4 January 1980 the Section of Anaesthetics of the Royal Society of Medicine joined with the British Anaesthetic and Respiratory Equipment Manufacturers Association (BAREMA) for a unique joint meeting on the subject of future developments in anaesthetic apparatus, The reasons behind this gathering might be termed 'problems with the new technology' because the last twenty years has seen an exponential growth in both the quantity and complexity of technology in clinical practice which daily confronts doctors, nurses and technicians alike. The anaesthetist has been particularly exposed to these incursions into his everyday life because of his expertise both in respiratory care and in the management of patients who require intensive care and therapy. The mini-computer and the microprocessor are making inroads into patient monitoring and display systems and into ventilating and anaesthetic apparatus.
What does the new technology aim to achieve and what exactly is it all about? First, there is the cover-up problem, that is the basic product is not really new at all but has simply been packaged .more adroitly and usually expensively. The consumer may perhaps be forgiven for not resisting the new lamps for old philosophy. Second, there is high level technology which is certainly expensive, over-complicated and also tries to convey by implication that there exists a lower level of technology which cannot do the job 0141-0768/81/120869-02/$01.00/0 so well. One of the problems with big machines, such as autoanalyzers, is their remoteness from the patient scene. On the other hand, smaller machines tend to dominate patient areas where additional help is not available and success depends upon interested clinicians or a system of graduates or technicians. Indeed, a First Law of medical technology may be formalized whereby the greater the number of functions.fhe less likely is it that (a) you need them or (b) they do exactly what you want. The Second Law is that the higher the level of the techology the greater the capability for harming the patient. It is difficult for a manufacturer to sell a lung ventilator without the option for a subatmospheric phase, despite the fact that this facility is virtually never required in modern clinical practice. Many lung ventilators on sale nowadays offer every conceivable facility imaginable, which includes a vast array of options, some of doubtful value, for respiratory programmes. 'The more knobs the better' seems to be the order of the day, but reassurance comes from some hospitals whose clinicians steadfastly recognize that if the intensive care nurses cannot manage the machine then it will not be any good.
The introduction of high level technology raises questions about standards and patient safety together with those about monitoring, the machine, let alone the patient. There .can be little doubt in the United Kingdom that the high costs of sophisticated equipment cannot be sustained and that a return to simpler, purposeful apparatus is needed. The days of the mighty Wurlitzer may indeed be numbered now it seems that less money from the NHS is being spent on new equipment. Those who are responsible for purchasing anaesthetic and respiratory equipment have a duty to anticipate the life of the equipment, to plan for its eventual replacement and to accommodate and recognize the maintenance and service costs in the meantime.
Manufacturers of medical equipment appear to work on two opposing principles, which can be termed 'market pull' and 'technological push'. Market pull represents the need for the production of equipment which clinicians ask manufacturers to develop and' manufacture. There are many doctors who have gone to equipment manufacturers with ideas only to suffer the disappointment of years passing by without 'anything happening before the idea is finally rejected. The problem seems to be that no manufacturer is going to reject any idea very quickly, thus effectively blocking potential competitors. Another problem is that the majority of British manufacturers have a vastly smaller market than, say, their North American counterparts. Technological push is the greater of the two forces and represents the fact that basic scientists or engineers get ideas or 'spin-offs' and put equipment onto the market. This writer has been completely unable to discover any market research done by British manufacturersapparently it does not exist. Part of the problem is that it is exceedingly difficult or financially impossible to get a sufficient body of consistent informed opinion amongst doctors on these matters. Manufacturers are also affected by possible changes in British and International Standards and the constraints imposed by legislation in the areas of product liability, product approval procedures, quality control and after-sales service and maintenance. Some of these problems have not yet materialized in the UK, e.g. product liability, but it is expected that its introduction may cause the cost of some equipment to increase, perhaps to up to ten times present values. On the other hand, patients should rightfully expect to receive a minimum standard of care as far as monitoring equipment, anaesthetic apparatus, breathing machines and so on are concerned. There is also the litigation problem where the question is asked: why wasn't such and such equipment available and in use when it is known that other hospitals already possess it? In many specialized fields, and neuroanaesthesia and anaesthesia for cardiac surgery are examples, the careful introduction of monitoring has revolutionized patient care. The anaesthetist has a better idea of his patient's behaviour to the surgery and to the administration of very potent drugs and is physically and psychologically able to offer an excellent service to patient and surgeon alike for what are very demanding, delicate and lengthy surgical procedures.
Some aspects of technological advances must be viewed with certain misgivings and suspicions. Mention has already been made of the marketing of 'old goods' in a bright new package, but other more human problems must be considered. These relate to hidden staff costs, the'removal of clinical staff from the patient interface and the problem of what to do with 'redundant' technical staff who have not kept up with these technological advances.
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